KLF17 Antibodies

Santa Cruz Biotechnology provides a broad selection of KLF17 monoclonal antibodies for research focused on understanding KLF17's role in various biological processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KLF17, or Krüppel-like factor 17, is a transcription factor that plays a crucial role in regulating gene expression related to cell differentiation, proliferation, and apoptosis. The involvement of KLF17 in various signaling pathways makes it significant in developmental biology and cancer research. Research has shown that KLF17 expression levels can vary significantly across different tissue types and developmental stages. Scientists have identified multiple binding partners and target genes of KLF17, expanding our understanding of its regulatory network. Investigating KLF17 can provide valuable insights into its potential as a therapeutic target in diseases where regulatory mechanisms are disrupted. Understanding the molecular mechanisms of KLF17 continues to reveal new possibilities in disease treatment and prevention. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of KLF17's biological significance and therapeutic potential.